Next-Generation Microcatheter for Embolic Agent Delivery Cleared by the FDA



PARK CITY, Utah, Nov. 30, 2023 /PRNewswire/ -- Transit Scientific, a Utah-based medical device company specializing in innovative solutions for vascular procedures, has announced the FDA clearance of its microcatheter designed for the precise delivery of a broad range of embolic agents. This milestone marks a significant advancement in microcatheter technology, offering clinicians a differentiating new tool to enhance patient care.

Microcatheters are commonly used to deliver therapeutic embolic agents, and inject contrast media, during complex endovascular procedures.­­

Current microcatheters come with various limitations, sacrificing low profile for flow rates, and sacrificing trackability for torque response. Current wire-braided catheters limit torquability and control, making it challenging to reach distal vasculature and oftentimes requiring catheter escalation. The current hypotube catheter designs limit trackability performance. Many current microcatheters also come with limitations on embolic compatibility and flow rates.

The XO Cath microcatheter is designed to deliver new levels of trackability, torque response, and embolic compatibility for improved treatment delivery. The non-tapered, metal-alloy construction is designed to offer unparalleled precision translating to superior control over embolic material placement, ensuring optimal results in minimally invasive procedures.

Dr. Richard Saxon of Tri-City Medical Center, a renowned interventional radiologist, shared their thoughts about the newly cleared microcatheter, saying, "This breakthrough technology could substantially improve the successful completion of embolic procedures. Its trackability, precision, and embolic compatibility features will likely make a significant difference in patient care."

This 510k clearance includes the XO Cath 2F Microcatheter with 0.021" ID for use with standard 0.014" and 0.018" guidewires, and the XO Cath 2.6F Microcatheter with 0.027" ID for use with standard 0.014", 0.018", and 0.035" guidewires. Both microcatheters are offered with either or straight or bern-shaped tip and are available in 90cm, 110cm, 130cm, 150cm, 175cm, and the class-leading 220cm working lengths for radial access procedures.

"This FDA clearance underscores our commitment to developing cutting-edge medical solutions that cater to the evolving needs of interventional radiologists," says Transit Scientific Chief Operations Officer, Jennifer Arnold. "This innovative microcatheter technology represents a fusion of innovation, precision, and safety, addressing critical challenges in embolic delivery procedures."

Transit Scientific is a privately held company dedicated to designing, developing, and commercializing medical devices. Their portfolio includes FDA-cleared XO Cath, XO Score® and XO Cross® platforms, as well as the XO CS Constrain for peripheral and coronary procedures currently in development, supported by over 20 issued and pending U.S. and global patents.

Media Contact: Kelly Himle

Cision View original content:

SOURCE Transit Scientific


Back to news